Longboard Pharmaceuticals, Inc. (LBPH)
NASDAQ: LBPH · IEX Real-Time Price · USD
18.01
+1.01 (5.94%)
Apr 18, 2024, 4:00 PM EDT - Market closed
Longboard Pharmaceuticals Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for LBPH stock have an average target of 36.14, with a low estimate of 13 and a high estimate of 60. The average target predicts an increase of 100.67% from the current stock price of 18.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LBPH stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 4 | 5 | 4 | 4 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 6 | 7 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +233.15% | Apr 16, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $60 | Buy | Reiterates | $60 | +233.15% | Apr 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $60 | Strong Buy | Maintains | $60 | +233.15% | Mar 15, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $60 | Buy | Reiterates | $60 | +233.15% | Mar 13, 2024 |
| Wedbush | Wedbush | Buy Reiterates $32 | Buy | Reiterates | $32 | +77.68% | Mar 13, 2024 |
Financial Forecast
Revenue This Year
2.55M
Revenue Next Year
n/a
from 2.55M
EPS This Year
-1.99
from -2.39
EPS Next Year
-2.48
from -1.99
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.8M | n/a | 21.7M | 180.6M | 422.1M |
| Avg | 2.6M | n/a | 7.1M | 57.8M | 201.5M |
| Low | n/a | n/a | n/a | n/a | 13.8M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | 2,448.0% | 630.6% |
| Avg | - | - | - | 715.1% | 248.7% |
| Low | - | - | - | - | -76.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.50 | -2.15 | -2.09 | -1.42 | 1.16 |
| Avg | -1.99 | -2.48 | -2.81 | -1.72 | -0.45 |
| Low | -2.34 | -2.80 | -3.38 | -1.98 | -1.94 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.